An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial

Eric J Velazquez1, Gary S Francis, Paul W Armstrong

  • 1Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27715, USA. velaz002@dcri.duke.edu

European Heart Journal
|November 4, 2004
PubMed

Insights

Heart failure (HF) and/or left ventricular systolic dysfunction (LVSD) are common after myocardial infarction (MI). These conditions significantly increase in-hospital mortality risk and complications for MI patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Heart failure (HF) and/or left ventricular systolic dysfunction (LVSD) significantly increase short- and long-term risks following myocardial infarction (MI).
  • The incidence, predictors, and outcomes of HF/LVSD in a large, international MI population require detailed description.

Purpose of the Study:

  • To analyze the contemporary incidence, outcomes, and predictors of HF and/or LVSD before discharge in acute myocardial infarction (MI) patients.
  • To assess the impact of HF/LVSD on in-hospital mortality and other cardiovascular events post-MI.

Main Methods:

  • Analysis of the VALIANT registry, including 5573 consecutive MI patients from 84 hospitals in nine countries (1999-2001).
  • Construction of a multivariable logistic survival model to determine adjusted mortality risk for patients with in-hospital HF/LVSD.
  • Testing baseline variables for associations with in-hospital HF/LVSD.

Main Results:

  • 42% of 5566 analyzed MI patients experienced HF and/or LVSD during hospitalization.
  • In-hospital mortality was 13.0% for patients with HF/LVSD versus 2.3% for those without.
  • In-hospital HF/LVSD was associated with a 4.12-fold increased hazard ratio for mortality and higher rates of other cardiovascular events.

Conclusions:

  • HF and/or LVSD are prevalent in contemporary MI patients, preceding 80.3% of in-hospital deaths.
  • Survivors of early MI-associated HF/LVSD face increased complications, longer hospital stays, and higher in-hospital mortality.
  • While baseline variables identify high-risk patients, they are less likely to receive indicated procedures and therapies.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
465
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
676